Sample collection
AML, ’
AML
The samples will be collected at the following time points: (i) at baseline, (ii) after salvage therapy, (iii) after consolidation therapy, (iv) after each cycle of consolidation therapy, (v) after each cycle of maintenance therapy, (vi) at the end of treatment, (vii) every 3 months during observational follow-up, and at end of study. Provided patients’ applicable informed consent is given, biological samples are stored to develop further knowledge and understanding of diagnostic, prognostic and predictive markers present in AML patients.